Acknowledging a difficult capital formation and financing climate, speakers at the recent BIO Investor Forum in San Francisco reportedly contended that strong science will prevail regardless and creative approaches to financing will help move promising technologies forward.  By exploring recent successful ventures, forum participants apparently learned how deals involving related biotech innovations with multiple potential uses can attract significant financial backing. While investment returns have not been strong in recent years and investors are more interested in later stage assets, opportunities exist for those planning carefully and efficiently. Some speakers reportedly expect more venture arms in the future among large pharmaceutical and biotech companies and more deals generated in this arena. See BIOtechNow, October 6, 2010.